Why Pfizer Halted Shipments of 1 of Its Top-Selling Products
Imagine having a product that generated sales of $919 million last year. Now picture having to stop deliveries of that product not just in one market but across the entire world. That's the situation that Pfizer (NYSE: PFE) finds itself in right now.
The healthcare giant recently revealed that it has suspended the global distribution of Chantix. The smoking cessation medication ranked as the company's eighth-best-selling product in 2020. Here's why Pfizer put the brakes on shipments of one of its top-selling products.
Image source: Getty Images.
Source Fool.com
